JERUSALEM, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended June 30, 2025.
*Architect-driven design meets American performance in the newest innovation from BMD Manufacturing.*
GALT, Calif., June 20, 2025 /PRNewswire/ -- INICIO™, a brand of BMD Manufacturing,...
GALT, Calif., June 19, 2025 /PRNewswire/ -- BMD, Inc., a leading distributor in the building materials industry, is pleased to announce the launch of...